z-logo
open-access-imgOpen Access
Jaffe–Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder
Author(s) -
Douglas R. Stewart,
Hilde Brems,
Alicia Gomes,
Sarah L. Ruppert,
Tom Callens,
Jennifer Williams,
Kathleen Claes,
Michael B. Bober,
Rachel K. Hachen,
Leonard B. Kaban,
Hua Li,
Angela E. Lin,
Marie McDonald,
Serge B. Melançon,
June Ortenberg,
Heather B. Radtke,
Ignace Samson,
Robert A. Saul,
Joseph Shen,
Elizabeth Siqveland,
Tomi L. Toler,
Merel van Maarle,
Margaret R. Wallace,
Misti Williams,
Eric Legius,
Ludwine Messiaen
Publication year - 2013
Publication title -
genetics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.509
H-Index - 128
eISSN - 1530-0366
pISSN - 1098-3600
DOI - 10.1038/gim.2013.163
Subject(s) - neurofibromatosis , germline mutation , medicine , neurofibromatosis type i , dermatology , pathology , mutation , genetics , biology , gene
"Jaffe-Campanacci syndrome" describes the complex of multiple nonossifying fibromas of the long bones, mandibular giant cell lesions, and café-au-lait macules in individuals without neurofibromas. We sought to determine whether Jaffe-Campanacci syndrome is a distinct genetic entity or a variant of neurofibromatosis type 1.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom